Market Insights Health Pharmacies OTC Products

Hand Sanitizer (Pharmacies) - Europe

Europe

Revenue in the Hand Sanitizer market is projected to reach €0.46bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 3.26%, resulting in a market volume of €0.54bn by 2029.
In global comparison, most revenue will be generated in China (€357.20m in 2024).
In relation to total population figures, per person revenues of €0.54 are generated in 2024.

Key regions: Japan, United States, Europe, United Kingdom, Canada

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Hand Sanitizer (Pharmacies) market in Europe has experienced significant growth in recent years, driven by changing customer preferences and local special circumstances.

Customer preferences: Customers in Europe have become increasingly concerned about personal hygiene and the spread of infectious diseases. This has led to a growing demand for hand sanitizers, particularly in pharmacies where customers can easily access these products. The convenience of purchasing hand sanitizers from pharmacies, along with the trust associated with these establishments, has made them a preferred choice for many consumers. Additionally, customers are now more conscious about the ingredients used in hand sanitizers, opting for products that are alcohol-based and effective against a wide range of germs.

Trends in the market: One of the key trends in the Hand Sanitizer (Pharmacies) market in Europe is the rising popularity of natural and organic hand sanitizers. Customers are increasingly seeking products that are free from harsh chemicals and are more environmentally friendly. This trend is driven by a growing awareness of the potential health risks associated with certain chemicals found in traditional hand sanitizers. As a result, pharmacies are now stocking a wider range of natural and organic hand sanitizers to cater to this demand. Another trend in the market is the increasing availability of hand sanitizers in different formats. While traditional hand sanitizers in liquid or gel form are still popular, pharmacies are now offering alternative formats such as wipes and sprays. This allows customers to choose the format that best suits their needs and preferences. Additionally, pharmacies are also offering hand sanitizers in travel-sized packaging, catering to the needs of customers who are constantly on the go.

Local special circumstances: Europe has a high population density, with many countries experiencing crowded urban areas. This has contributed to the increased focus on personal hygiene and the demand for hand sanitizers. In densely populated cities, the risk of infectious diseases spreading quickly is higher, leading to a greater emphasis on preventive measures such as hand hygiene. Pharmacies play a crucial role in providing easy access to hand sanitizers for residents in these areas.

Underlying macroeconomic factors: The Hand Sanitizer (Pharmacies) market in Europe is also influenced by underlying macroeconomic factors. The region has a well-developed healthcare system, with pharmacies playing a key role in providing healthcare products and services. This has created a favorable environment for the growth of the hand sanitizer market in pharmacies. Additionally, the increasing focus on health and hygiene has led to higher consumer spending on personal care products, including hand sanitizers. The overall economic stability in Europe has also contributed to the growth of the market, as consumers have more disposable income to spend on these products. In conclusion, the Hand Sanitizer (Pharmacies) market in Europe is witnessing significant growth due to changing customer preferences, including the demand for natural and organic products, and the availability of hand sanitizers in different formats. The local special circumstances, such as high population density and the role of pharmacies in the healthcare system, further contribute to the market's development. The underlying macroeconomic factors, including the well-developed healthcare system and economic stability, also play a role in driving the growth of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.